In This Section
 

Meet the Keynote Speakers

Here are the 2023 Annual Meeting Keynote Speakers Reflecting on Science, Success, and the Future.

Internationally Renowned Neuroscientist

Yasmin Hurd, PhD | Director, Addiction Institute at Mount Sinai

Dr. Yasmin Hurd is the Director of the Addiction Institute within the Mount Sinai Behavioral Health System as well as the Ward Coleman Chair of Translational Neuroscience and Professor of Psychiatry and Neuroscience at the Icahn School of Medicine at Mount Sinai in New York. Dr. Hurd is an internationally renowned neuroscientist whose translational research examines the neurobiology of drug abuse and related psychiatric disorders. Her research exploring the neurobiological effects of cannabis and heroin has significantly shaped the field. She uses multidisciplinary approaches to provide unique insights into the impact of developmental cannabis exposure and epigenetic mechanisms underlying the drug’s protracted effects into adulthood and even across generations. Dr. Hurd is a member of the National Academy of Medicine and the National Academy of Sciences. She is also the recipient of the 2020 Mika Salpeter Lifetime Achievement Award from the Society for Neuroscience.

Nobel Prize-winning Physician

William G. Kaelin, MD | Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute

Dr. William Kaelin is the Sidney Farber Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute, Senior Physician in Medicine at Brigham and Women's Hospital and Howard Hughes Medical Institute Investigator. A Nobel Laureate, Dr. Kaelin received the 2019 Nobel Prize in Physiology or Medicine. Dr. Kaelin’s research seeks to understand how, mechanistically, mutations affecting tumor-suppressor genes cause cancer. His laboratory is currently focused on studies of the VHL, RB-1, and p53 biochemical functions of tumor suppressor genes. The team uses genetic and biochemical approaches with both human and mouse cells, including genetically engineered mouse models. He is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, the National Academy of Medicine, the American Society of Clinical Investigation, and the American College of Physicians.

Science  Journal Editor-in-Chief

Holden Thorp, PhD | Rita Levi-Montalcini Distinguished University Professor

Dr. Holden Thorp became Editor-in-Chief of the Science family of journals in October 2019. He joined the Science journals from Washington University, where he was provost from 2013 to 2019 and where he is Rita Levi-Montalcini Distinguished University Professor and holds appointments in both chemistry and medicine. Dr. Thorp joined Washington University after spending three decades at the University of North Carolina at Chapel Hill, where he served as the 10th chancellor from 2008 through 2013. In his research career, Dr. Thorp studied electron-transfer reactions of nucleric acid, developed technology for electronic DNA chips, and cofounded Viamet Pharmaceuticals, which developed VIVJOA (oteseconazole), now approved by the FDA. Dr. Thorp is a fellow of the American Academy of Arts and Sciences, the National Academy of Inventors, and the American Association for the Advancement of Science.

Job Postings

Last Updated: November 8, 2022

Job Postings